Albumin-Bound Paclitaxel: all 674 studies that test it

Page 5 of 7. Open to participants first (177), then studies with results posted, then the rest; newest registration first within each.

• Nab-paclitaxel Based TPX Neoadjuvant Chemotherapy for NPC Patients: a Dose-escalation StudyActive, not recruitingNCT04850235Phase 1
• Pancreatic Cancer With Elevated Serum CA125 Were Compared With Those Who Did Not Receive Neoadjuvant Chemotherapy.Status unknownNCT04835064Phase 3
• Nab-Paclitaxel in Combination With Nivolumab to Treat Recurrent or Metastatic Head and Neck Squamous-Cell Carcinoma That Progressed on a PD-1 or PD-L1 InhibitorActive, not recruitingNCT04831320Phase 2
• Study to Evaluate the Safety and Efficacy of Treatment With NLM-001 and Standard Chemotherapy Plus Zalifrelimab in Patients With Advanced Pancreatic CancerActive, not recruitingNCT04827953Phase 1/2
• POL6326 (Balixafortide) Plus Nab-paclitaxel or Eribulin in Patients With HER2-negative Advanced Breast CancerWithdrawnNCT04826016Phase 1/2
• Efficacy and Safety of SHR-1020 Combined With Albumin-bound Paclitaxel in the Second-line Treatment of Pancreatic CancerStatus unknownNCT04814485Phase 2
• Neoadjuvant Nab-Paclitaxel and S-1 in Resectable Pancreatic CancerStatus unknownNCT04808687Phase 2
• Albumin-bound Paclitaxel Combination With Capecitabine Versus Capecitabine Monotherapy in Paclitaxel/Docetaxel-resistant Advanced Breast CancerStatus unknownNCT04780347Phase 2
• Albumin-bound Paclitaxel Combined With Cisplatin Versus Docetaxel Combined With Cisplatin Induced Chemotherapy in Advanced Head and Neck Squamous TummorStatus unknownNCT04766827Phase 4
• Study of Pembrolizumab With Single Agent Chemotherapy in Elderly Patients With Advanced NSCLCWithdrawnNCT04754815Phase 2
• Multi-agent Low Dose Chemotherapy GAX-CI Followed by Olaparib and Pembro in Metastatic Pancreatic Ductal Cancer.Active, not recruitingNCT04753879Phase 2
• A Phase II Study to Explore the Safety, Tolerability, and Preliminary Antitumor Activity of Sitravatinib Plus Tislelizumab or Combination With Nab-paclitaxel in Patients With Locally Recurrent or Metastatic Triple Negative Breast Cancer (TNBC)Active, not recruitingNCT04734262Phase 2
• Tilelizumab Combined With Nab-Paclitaxel for High-Risk Non-Muscle-Invasive Urothelial Bladder Carcinoma Which is Not Completely ResectableStatus unknownNCT04730232Phase 2
• Perioperative Tislelizumab Combined With Nab-Paclitaxel for Muscle-invasive Urothelial Bladder CarcinomaStatus unknownNCT04730219Phase 2
• Toripalimab Combined With Bevacizumab, Nab-paclitaxel and Carboplatin for Untreated Metastatic Pulmonary Sarcomatoid CarcinomaStatus unknownNCT04725448Phase 2
• Efficacy and Safety of Sintilimab and Apatinib Combined Chemotherapy in Breast CancerStatus unknownNCT04722718Phase 2
• Anlotinib, Toripalimab and Nab-paclitaxel in Locally Advanced/Metastatic Pancreatic CancerStatus unknownNCT04718701Phase 2
• A Phase II Study for Nab-paclitaxel Plus Cisplatin vs Gemcitabine Plus Cispatin as First Line Chemotherapy in Advanced Biliary Tract CancerStatus unknownNCT04692051Phase 2
• Clinical Trial to Investigate Safety, Tolerability and MTD for SCO-101 in Combination With Gemcitabine and Nab-paclitaxel in Inoperable Pancreatic Cancer Patients.Status unknownNCT04652206Phase 1/2
• Pyrotinib, Trastuzumab And Abraxane in HER2-positive MBC With Brain MetastasisStatus unknownNCT04639271Phase 2
• Trial of First-line L-glutamine With Gemcitabine and Nab-paclitaxel in Advanced Pancreatic CancerCompletedNCT04634539Phase 1
• AG vs mFOLFIRINOX as Neoadjuvant Therapy for Borderline Reseactable and Locally Advanced Pancreatic CancerStatus unknownNCT04617821Phase 3
• A Study of Anti-PD-L1 Antibody ZKAB001 Combined With Albumin-bound Paclitaxel in Advanced Urothelial CarcinomaStatus unknownNCT04603846Phase 1
• Apatinib Combined With Abraxane and Carboplatin or Cisplatinum as First-line Treatment for Epithelial Ovarian CancerStatus unknownNCT04590625Phase 2
• The Safety and Efficacy of the Combination of Raltitrexed for Injection and Nab-Paclitaxel in Advanced Pancreatic CancerStatus unknownNCT04581876Phase 2
• Nab-PTX, Ifosfamide and Cisplatin in the Treatment of Pediatric Extracranial Germ Cell Tumor.Status unknownNCT04581265Phase 2
• Camrelizumab Combined With Apatinib Mesylate Tablets and Nab-paclitaxel in the Second-line Treatment of Advanced Gastric CancerStatus unknownNCT04572542Phase 1/2
• Efficacy and Safety of Toripalimab Combined With Docetaxel or Nab-paclitaxel in Patients With Advanced Gastric CancerStatus unknownNCT04563975Phase 2
• Efficacy and Safety of Preoperative Sintilimab Plus Nab-paclitaxel and Cisplatin in BR-ESCC PatientsCompletedNCT04548440Phase 2
• Chemo4METPANC Combination Chemokine Inhibitor, Immunotherapy, and Chemotherapy in Pancreatic AdenocarcinomaActive, not recruitingNCT04543071Phase 2
• Neoadjuvant Camrelizumab, Nab-paclitaxel and Carboplatin in Stage IB-IIIA NSCLCStatus unknownNCT04541251Phase 2
• First-line Nab-paclitaxel Plus Cisplatin Plus Camrelizumab in mTNBC PatientsCompletedNCT04537286Phase 2
• Ultrasound-based Blood-brain Barrier Opening and Albumin-bound Paclitaxel and Carboplatin for Recurrent GlioblastomaActive, not recruitingNCT04528680Phase 1/2
• Efficacy and Safety of Camrelizumab Combined With Nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic CancerStatus unknownNCT04498689Phase 2
• Clinical Study of Nab-paclitaxel Combined With Toripalimab in Local Advanced or Metastatic G/GEJ CarcinomaStatus unknownNCT04443036Not applicable
• A Study of QL1604 Plus Nab-paclitaxel Versus Paclitaxel in Subjects With Advanced Gastric Cancer.Status unknownNCT04435652Phase 2/3
• An Umbrella Trial Based on Molecular Pathway for Patients With Metastatic TNBC.Active, not recruitingNCT04395989Phase 2
• Neoadjuvant Chemotherapy With Nab-paclitaxel Plus Cisplatin and Capecitabine for Locally Advanced Thoracic Esophageal Squamous Cell CarcinomaStatus unknownNCT04390958Phase 2
• Combination Immunotherapy Plus Standard-of-Care Chemotherapy Versus Standard-of-Care Chemotherapy for the Treatment of Locally Advanced or Metastatic Pancreatic CancerActive, not recruitingNCT04390399Phase 2
• Molecularly Targeted Umbrella Study in Luminal Advanced Breast CancerStatus unknownNCT04355858Phase 2
• Neoadjuvant Toripalimab Plus Platinum-based Doublet for Stage III Non-small Cell Lung CancerActive, not recruitingNCT04304248Phase 2
• Efficacy and Safety of Albumin Paclitaxel Combined With Cisplatin Chemoradiotherapy for Non-resectable Stage III NSCLCStatus unknownNCT04284215Not applicable
• Neoadjuvant Chomotherapy With Paclitaxel-albumin and S-1 for Advanced Gastric CancerStatus unknownNCT04258657Phase 2
• Camrelizumab in Combination With Apatinib Mesylate, Paclitaxel-albumin and S-1 for Translational Treatment of Gastric CancerStatus unknownNCT04258644Phase 2
• Safety and Tolerance of Epigenetic and Immunomodulating Drugs Combined With Chemotherapeutics in Patients Suffering From Advanced Pancreatic CancerCompletedNCT04257448Phase 1/2
• Cryoablation, Atezolizumab/Nab-paclitaxel for Locally Advanced or Metastatic Triple Negative Breast CancerWithdrawnNCT04249167Early Phase 1
• Nivolumab, Ipilimumab and Chemoradiation in Pancreatic Cancer.CompletedNCT04247165Phase 1/2
• Comparing Two Treatment Combinations, Gemcitabine and Nab-Paclitaxel With 5-Fluorouracil, Leucovorin, and Liposomal Irinotecan for Older Patients With Pancreatic Cancer That Has SpreadActive, not recruitingNCT04233866Phase 2
• Nab-P and Gem Compared With Gem and Tegafur in Adjuvant Chemotherapy After Radical Resection of Pancreatic CancerStatus unknownNCT04216758Phase 2
• Nab-paclitaxel Versus Topotecan As Second-Line Treatment for Patients With Extensive Stage Small Cell Lung CancerStatus unknownNCT04213937Phase 2
• SHR-1210 Combined With Albumin-bound Paclitaxel and Epirubicin Neoadjuvant for Triple Negative Breast CancerStatus unknownNCT04213898Phase 1/2
• A Study on Toripalimab Plus Nab-Paclitaxel With or Without Cisplatin as First-line Treatment of Urothelial CarcinomaStatus unknownNCT04211012Phase 2
• Nab-Paclitaxel in Patients With ER+/HER2- Recurrent Metastatic Breast CancerStatus unknownNCT04194684Phase 2
• Camrelizumab, Apatinib and Nab-paclitaxel as Second-line Treatment in Advanced Gastric CancerStatus unknownNCT04182724Phase 1/2
• SHR- 1210 Combined With Paclitaxel (Albumin Bound) and Gemcitabine as First-line Therapy in Patients With Metastatic Pancreatic CancerCompletedNCT04181645Not applicable
• Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic CancerSuspendedNCT04158635Phase 1
• Pyrotinib Maleate Tablets Combined With Albumin Paclitaxel and Trastuzumab for Her2-positive Breast CancerStatus unknownNCT04152057Phase 1/2
• A Clinical Study to Evaluate Efficacy and Safety of HLX10 Combined With Albumin-Bound Paclitaxel in Patients With Advanced Cervical Cancer Who Have Progressive Disease or Intolerable Toxicity After First-Line Standard ChemotherapyStatus unknownNCT04150575Phase 2
• Sintilimab and Nab-paclitaxel in Second-line Treatment of Advanced Gastric or Gastro-oesophageal Junction AdenocarcinomaStatus unknownNCT04140318Phase 2
• Nab-paclitaxel Combined With S-1 as Adjuvant Chemotherapy for Stage Ⅲ Gastric CancerStatus unknownNCT04135781Phase 3
• Biologically Optimized Infusion Schedule of Gemcitabine and Nab-Paclitaxel for the Treatment of Metastatic Pancreatic CancerActive, not recruitingNCT04115163Phase 2
• Efficacy and Safety Study of Nab-Paclitaxel Combined With Cisplatin in Second or Later-Line Treatment in Advanced Biliary Tract CancersStatus unknownNCT04111380Phase 2
• Paclitaxel (Albumin-bound) and Oxaliplatin for Advanced Hepatobiliary and Malignant TumorsStatus unknownNCT04060472Phase 2/3
• Efficacy and Safety of IBI308 and Paclitaxel/Albumin Paclitaxel for SCLC Patients Who Failed Etoposide ChemotherapyStatus unknownNCT04056949Phase 2
• Study of Lonsurf in Combination With Gemcitabine and Nab-Paclitaxel in Patients With Advanced (PDAC)TerminatedNCT04046887Phase 1
• VMAT Concurrent Cisplatin Plus Nab-paclitaxel for Local Advanced Cervical CancerStatus unknownNCT04017377Not applicable
• A Exploratory Study of Nivolumab Monotherapy or in Combination With Nab-paclitaxel and Carboplatin in Early Stage NSCLC in ChinaActive, not recruitingNCT04015778Phase 2
• Induction Chemotherapy Followed by Concurrent Chemoradiotherapy in Patients With LA-NPCStatus unknownNCT04015661Phase 2
• Induction Chemotherapy With Nab-paclitaxel, Cisplatin and Fluorouracil for Locoregionally Advanced Nasopharyngeal CarcinomaCompletedNCT04004871Phase 2
• A Phase I/II Study of the Pan-immunotherapy in Patients With Local Advanced/Metastatic BTCStatus unknownNCT04004234Phase 1/2
• PIPAC With Nab-paclitaxel and Cisplatin in Peritoneal CarcinomatosisActive, not recruitingNCT04000906Phase 1
• Pegylated Liposomal Doxorubicin Plus Albumin-Bound Paclitaxel and Trastuzumab in HER-2 Positive Breast CancerStatus unknownNCT03994107Phase 1/2
• Sintilimab in Combination With Nab-paclitaxel in Patients With HNSCC (Head and Neck Squamous Cell Carcinoma )Status unknownNCT03975270Phase 2
• Paclitaxel Injection (Albumin-bound) for Neoadjuvant Treatment of Breast CancerStatus unknownNCT03959397Phase 2
• Gemcitabine + Oxaliplatin +Nab-paclitaxel in Subjects With Advanced Biliary Tract CancerStatus unknownNCT03943043Phase 1/2
• Apatinib With Albumin-bound Paclitaxel in Patients With Platinum-resistant Recurrent Ovarian CancerStatus unknownNCT03942068Phase 2
• Nab-paclitaxel and Gemcitabine in Metastatic Pancreatic CancerStatus unknownNCT03929094Phase 2
• Pyrotinib in Combination With Nab-paclitaxel in Patients With HER2-positive Advanced Breast Cancer: an Exploratory StudyStatus unknownNCT03919253Phase 2
• High Dose Ascorbic Acid and Nanoparticle Paclitaxel Protein Bound and Cisplatin and Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic CancerWithdrawnNCT03908333Phase 1/2
• Neoadjuvant Nab-paclitaxel in Triple-negative or HER2-positive Breast CancerStatus unknownNCT03907800Phase 2
• Nab-paclitaxel and S-1 in Patients With Locally Advanced Pancreatic CancerStatus unknownNCT03885219Phase 2
• Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME TrialTerminatedNCT03878524Phase 1
• A Study of KN046 in Subjects With Locally Advanced or Metastatic Triple-negative Breast CancerCompletedNCT03872791Phase 1/2
• Neoadjuvant Nab-Paclitaxel and S-1 in Borderline Resectable Pancreatic CancerStatus unknownNCT03850769Phase 2
• The Efficacy and Safety of Nab-paclitaxel Plus S-1 in First-line Treatment of Advanced Biliary Tract AdenocarcinomaCompletedNCT03830606Phase 2
• A Trial of NS/GEMOX Chemotherapy in Patients With Untreated Pancreatic Cancer ( HZ-NS/GEMOX-PC )Status unknownNCT03825328Phase 2
• Nab-paclitaxel Combined With S-1 as Induction Therapy for Locally Advanced Pancreatic CancerStatus unknownNCT03815461Phase 2
• FUSCC Refractory TNBC Umbrella (FUTURE)Status unknownNCT03805399Phase 1/2
• Concurrent Nab-P/Carboplatin and Thoracic Radiotherapy in Squamous Cell Lung CancerTerminatedNCT03802058Phase 2
• Albumin-bound Paclitaxel Plus S-1 Versus SOX as First-line Treatment in Advanced or Recurrent Gastric AdenocarcinomaStatus unknownNCT03801668Phase 3
• A Study to Evaluate Safety/Tolerability of Immunotherapy Combinations in Participants With Triple-Negative Breast Cancer or Gynecologic MalignanciesCompletedNCT03719326Phase 1
• Gemcitabine & Nab-Paclitaxel in Pancreatic Adenocarcinoma With Positive Peritoneal CytologyStatus unknownNCT03703089Phase 1
• Alternative Neoadjuvant Chemotherapy in Resectable and Borderline Resectable Pancreatic CancerStatus unknownNCT03703063Phase 1
• High Dose Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic CancerWithdrawnNCT03697239Phase 1/2
• First Line Metastatic Pancreatic Cancer : 5FU/LV+Nal-IRI, Gemcitabine+Nab-paclitaxel or a Sequential Regimen of 2 Months 5FU/LV+Nal-IRICompletedNCT03693677Phase 2
• Abraxane Combined With Xeloda as Neo-Adjuvant Chemotherapy in Early Breast CancerStatus unknownNCT03647514Not applicable
• The Efficacy and Safety of Abraxane Combined With Epirubicin as Neoadjuvant Chemotherapy in Breast CancerStatus unknownNCT03647280Not applicable
• Trial of Neoadjuvant Chemotherapy With S1 Plus Paclitaxel-albumin on Pancreatic CancerTerminatedNCT03585062Phase 2
• QUILT-3.072: NANT Hepatocellular Carcinoma (HCC) VaccineWithdrawnNCT03563170Phase 1/2
• QUILT-3.088: NANT Pancreatic Cancer VaccineWithdrawnNCT03563144Phase 2

← Albumin-Bound Paclitaxel overview